EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The implications of abnormal signal patterns of break-apart FISH probes used in the diagnosis of bone and soft tissue tumours

Hongtao Ye, Fitim Berisha, Evie Rowles, Emani Munasinghe, Christopher Davies, Akanksha Farswan, Nischalan Pillay

Pathology and Oncology Research · 2025

DOI: 10.3389/pore.2025.1612142 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathology and Oncology Research, 2025. Verfasst von Hongtao Ye und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cellular and Molecular Pathology, Royal National Orthopaedic Hospital, Stanmore, United Kingdom. Hauptthemen laut MEDLINE: In Situ Hybridization, Fluorescence, Soft Tissue Neoplasms, Bone Neoplasms, Biomarkers, Tumor. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Many subtypes of bone and soft tissue tumours harbour specific chromosome translocations leading to chimeric fusion genes. The identification of these specific fusion genes is the basis of molecular diagnoses in such tumours. Break-apart FISH is a robust method that is commonly used to identify these translocations and provide diagnostic support to histological interpretations. The signal patterns of the break-apart probes are usually easily interpreted. However, some cases show abnormal signal patterns leading to equivocal and challenging interpretation. The incidence of these abnormal patterns is largely unknown. Using a retrospective cohort we explored the incidence of abnormal signal patterns across common bone and soft tissue tumour types to raise awareness of this occurrence and to aid in the interpretation. In total, 1,087 bone and soft tissue tumours tested by break-apart probes were examined. The abnormal signal patterns were classified as deletion, additional copy and amplification, which were found at highest frequency in low-grade fibromyxoid sarcoma (32%, 6/19), and at moderate frequencies in those from alveolar rhabdomyosarcoma (10%, 9/94), nodular fasciitis (9%, 18/209), synovial sarcoma (8%, 17/207) and Ewing sarcoma/round cell sarcoma with EWSR1-non-ETS fusions (6%, 29/497). The lowest frequency was found in clear cell sarcoma (1%, 1/61). Despite the equivocal results from the abnormal signal patterns, the specific fusion genes were confirmed by orthogonal molecular techniques such as FISH with fusion probes, RT-PCR or next-generation sequencing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

In Situ Hybridization, FluorescenceSoft Tissue NeoplasmsBone NeoplasmsBiomarkers, TumorHumansRetrospective StudiesOncogene Proteins, FusionTranslocation, GeneticFemale

Stichwörter der Autor:innen

FISHabnormal signal patternbone and soft tissue tumourbreak-apart probecancergene rearrangementgenomicstranslocation

Substanzen

Oncogene Proteins, FusionBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Cellular and Molecular Pathology, Royal National Orthopaedic Hospital, Stanmore, United Kingdom.
  • Cancer Institute, University College London, London, United Kingdom.

Zitieren

APA

Ye, H., Berisha, F., Rowles, E., Munasinghe, E., Davies, C., Farswan, A., & Pillay, N. (2025). The implications of abnormal signal patterns of break-apart FISH probes used in the diagnosis of bone and soft tissue tumours. Pathology and Oncology Research. https://doi.org/10.3389/pore.2025.1612142

Vancouver

Ye H, Berisha F, Rowles E, Munasinghe E, Davies C, Farswan A, et al. The implications of abnormal signal patterns of break-apart FISH probes used in the diagnosis of bone and soft tissue tumours. Pathology and Oncology Research. 2025. doi:10.3389/pore.2025.1612142

BibTeX
@article{Ye2025,
  author = {Ye, Hongtao and Berisha, Fitim and Rowles, Evie and Munasinghe, Emani and Davies, Christopher and Farswan, Akanksha and Pillay, Nischalan},
  title = {The implications of abnormal signal patterns of break-apart FISH probes used in the diagnosis of bone and soft tissue tumours},
  journal = {Pathology and Oncology Research},
  year = {2025},
  doi = {10.3389/pore.2025.1612142}
}
Kostenlos starten →